Meanwhile, pharmacological activation of Rev‐erbα by synthetic ligands revealed its therapeutic effect for improving calcium homeostasis in cells obtained from patients with Duchenne muscular dystrophy and for mitigating the myopathic mouse phenotype. This evidence concerns the gene NR1D1 and Duchenne muscular dystrophy.